Periodic Knowledge Assessment Survey of Healthcare Providers (HCPs) to Assess Understanding of the Risks with the Prolia® Risk Evaluation and Mitigation Strategy (REMS)

First published 12/12/2024

Last updated 06/08/2026

EU PAS number:

EUPAS1000000393

Study

Ongoing

Documents

Study protocol

Initial protocol

Protocol-Published Amendment denosumab 20240121 3 .pdf

English (748.08 KB - PDF) View document

Updated protocol

Protocol-Published Amendment denosumab 20240121 3 .pdf

First published: 06/08/2026

English (1.2 MB - PDF) View document

Study results

Study report

Other information

Secondary tabs